Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
OTC Markets EXMKT - Delayed Quote USD

Black Bird Biotech, Inc. (BBBT)

Compare
0.0001
+0.0001
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
36.3230
82.5630
104.4580
57.6040
Cost of Revenue
23.0160
49.5510
84.8710
28.2450
Gross Profit
13.3070
33.0120
19.5870
29.3590
Operating Expense
327.9620
1,321.3450
1,470.7140
709.7010
Operating Income
-314.6550
-1,288.3330
-1,451.1270
-680.3420
Net Non Operating Interest Income Expense
-521.6340
-370.5870
-285.3270
-5.8730
Other Income Expense
--
0.1540
-74.8480
-3.9430
Pretax Income
-836.1350
-1,658.7660
-1,811.3020
-690.1580
Net Income Common Stockholders
-836.1350
-1,658.7660
-1,811.3020
-690.1580
Diluted NI Available to Com Stockholders
-836.1350
-1,658.7660
-1,811.3020
-690.1580
Basic EPS
-0.00
-0.01
-0.01
-0.01
Diluted EPS
-0.00
-0.01
-0.01
-0.01
Basic Average Shares
746,041.4680
330,728.4890
194,420.0010
120,358.9310
Diluted Average Shares
1,753,292.9690
806,448.9240
225,537.8110
132,545.4400
Total Operating Income as Reported
-399.0990
-1,288.3330
-1,451.1270
-684.8030
Rent Expense Supplemental
7.4320
4.8000
10.3200
17.2000
Total Expenses
350.9780
1,370.8960
1,555.5850
737.9460
Net Income from Continuing & Discontinued Operation
-836.1350
-1,658.7660
-1,811.3020
-690.1580
Normalized Income
-836.1350
-1,658.7660
-1,736.4540
-685.6970
Interest Expense
521.9850
370.5870
285.3270
5.8730
Net Interest Income
-521.6340
-370.5870
-285.3270
-5.8730
EBIT
-314.1500
-1,288.1790
-1,525.9750
-684.2850
EBITDA
-25.5140
-1,199.2610
-1,416.3180
-684.2850
Reconciled Cost of Revenue
23.0160
49.5510
84.8710
28.2450
Reconciled Depreciation
288.6360
88.9180
109.6570
--
Net Income from Continuing Operation Net Minority Interest
-836.1350
-1,658.7660
-1,811.3020
-690.1580
Total Unusual Items Excluding Goodwill
--
--
-74.8480
-4.4610
Total Unusual Items
--
--
-74.8480
-4.4610
Normalized EBITDA
-25.5140
-1,199.2610
-1,341.4700
-679.8240
12/31/2020 - 11/11/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GRPS Gold River Productions, Inc.
0.0002
-25.00%
 
TLPH Talphera, Inc.
0.5020
-1.74%
 
SIGA SIGA Technologies, Inc.
5.33
-1.11%
 
ESPR Esperion Therapeutics, Inc.
1.2000
-2.44%
 
DVAX Dynavax Technologies Corporation
12.49
-1.26%
 
AKBA Akebia Therapeutics, Inc.
1.7700
0.00%
 
ZTS Zoetis Inc.
149.10
-1.73%